Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 5, Mai 2005
Page(s) 498 - 502
Section M/S revues
Publié en ligne 15 mai 2005
  1. Woessner JF, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1998; 263 : 16918–25.
  2. Imai K, Yokohama Y, Nakanishi I, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270 : 6691–7.
  3. Powell WC, Domann FE Jr, Mitchen JM, et al. Matrilysin expression in the involuting ventral prostate. Prostate 1996; 29 : 159–68.
  4. Wilson CL, Heppner KJ, Labosky PA, et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloprotease matrilysin. Proc Natl Acad Sci USA 1997; 94 : 1402–7.
  5. Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinol 2002; 34 : 59–63.
  6. Matsuno K, Adachi Y, Yamamoto H, et al. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 2003; 38 : 348–54.
  7. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinoma. Implication for vessel invasion and metastasis. Int J Cancer 1998; 79 : 187–94.
  8. Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett’s oesophageal adenocarcinoma. Br J Cancer 2001; 85 : 383–92.
  9. Tanioka Y, Yoshida T, Ygawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 2003; 89 : 2116–21.
  10. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999; 59 : 3313–16.
  11. Ishikawa T, Ichikawa Y, Mitsuhashi M, et al. Matrilysin is associated with progression of colorectal tumor. Cancer Lett 1996; 107 : 5–10.
  12. Masaki T, Sugiyama M, Matsuoka H, et al. Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig Dis Sci 2003; 48 : 1262–67.
  13. Kioi M, Yamaoto K, Higashi S, et al. Matrilysin (MMP7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 2003; 22 : 8662–70.
  14. Weinfass B, Nejjari M, Trespeuch C, et al. Effets de la bombésine sur l’expression de la matrilysine MMP7 dans la lignée cancéreuse colique humaine Isreco 1. Gastroenterol Clin Biol 2004; 28 : 161.
  15. Wroblewski LE, Noble PJM, Pagliocca A, et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells : role in epithelial cell migration. J Cell Sci 2003; 116 : 3017–26.
  16. Nagashima Y, Hasegawa S, Koshikawa N, et al. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer 1997; 72 : 441–5.
  17. Huo N, Ichikawa Y, Kamiyama M, et al. MMP7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002; 177 : 95–100.
  18. Pozzi A, Moberg PE, Miles LA, et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000; 97 : 2202–7.
  19. Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin (MMP-7) expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001; 3 : 459–68.
  20. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellualr cleavage of E-cadherin from prostate cancer cells : a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Canc Res 2001; 7 : 3289–97.
  21. McGuire J, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003; 162 : 1831–43.
  22. Wilson CL, Matrisian LM. Matrilysin : an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996; 28 : 123–36.
  23. Von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of béta4 integrin by matrilysin. Exp Cell Res 1997; 236 : 341–5.
  24. Bair EL, Massey CP, Tran NL, et al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001; 270 : 259–67.
  25. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003; 201 : 528–34.
  26. Brabletz T, Jung A, Dag S, et al. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155 : 1033–8.
  27. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic béta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 2002; 122 : 60–71.
  28. Brabletz T, Jung A, Kirchner T. β-catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002; 441 : 1–11.
  29. Ozaki I, Mizuta T, Yotsumoto H, et al. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000; 60 : 19–25.
  30. Udayakumar TS, Stratton MS, Nagle RB, Bowden GT. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular regulated kinases and STAT3. Neoplasia 2002; 4 : 60–7.
  31. Lynch CC, Crawford HC, Matrisian LM, McDonnell S. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. Int J Oncol 2004; 24 : 1565–72.
  32. Yamamoto H, Iku S, Adachi Y, et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003; 199 : 176–184.
  33. Ueno H, Yamashita K, Azumano I, et al. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinoma. Int J Cancer 1999; 84 : 470–7.
  34. Yu WH, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000; 275 : 4183–91.
  35. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Met Rev 2003; 22 : 145–52.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.